4.3 Review

Adverse pregnancy outcomes and cardiovascular risk factor management

Journal

SEMINARS IN PERINATOLOGY
Volume 39, Issue 4, Pages 268-275

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.semperi.2015.05.005

Keywords

Women; Cardiovascular disease; Pre-eclampsia; Gestational diabetes

Funding

  1. Gilead
  2. General Electric
  3. NIH
  4. CTSI
  5. FAMRI

Ask authors/readers for more resources

Cardiovascular disease (CVD) is the leading health threat to American women. In addition to establish risk factors for hypertension, hyperlipidemia, diabetes, smoking, and obesity, adverse pregnancy outcomes (APOs) including pre-eclampsia, eclampsia, and gestational diabetes are now recognized as factors that increase a woman's risk for future CVD. CVD risk factor burden is disproportionately higher in those of low socioeconomic status and in ethnic/racial minority women. Since younger women often use their obstetrician/gynecologist as their primary health provider, this is an opportune time to diagnose and treat CVD risk factors early. Embedding preventive care providers such as nurse practitioners or physician assistants within OB/GYN practices can be considered, with referral to family medicine or internist for ongoing risk assessment and management. The American Heart Association (AHA)/American Stroke Association (ASA) stroke prevention guidelines tailored to women recommend that women with a history of pre-eclampsia can be evaluated for hypertension and other CVD risk factors within 6 months to 1-year post-partum. Given the burden and impact of CVD on women in our society, the entire medical community must work to establish feasible practice and referral patterns for assessment and treatment of CVD risk factors. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Cardiac & Cardiovascular Systems

Stem Cell Therapy Targets: Repechage!

C. Noel Bairey Merz, Eduardo Marban

CIRCULATION RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Coronary Arterial Function and Disease in Women With No Obstructive Coronary Arteries

Harmony R. Reynolds, C. Noel Bairey Merz, Colin Berry, Rohit Samuel, Jacqueline Saw, Nathaniel R. Smilowitz, Ana Carolina do A. H. de Souza, Robert Sykes, Viviany R. Taqueti, Janet Wei

Summary: Ischemic heart disease is the leading cause of mortality in women and requires gender-specific risk stratification for prevention, diagnosis, and treatment. Recent research has improved understanding of cardiovascular disease in women, including mechanisms of ischemia with no obstructive coronary arteries and myocardial infarction with no obstructive coronary arteries. Despite progress, sex differences in ischemic heart disease outcomes persist.

CIRCULATION RESEARCH (2022)

Editorial Material Cardiac & Cardiovascular Systems

A Scientific Imperative as Seen Through a Sharpened Lens: Sex, Gender, and the Cardiovascular Condition

Natalie A. Bello, C. Noel Bairey Merz, Susan Cheng

CIRCULATION RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Autologous CD34+Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction

Timothy D. Henry, C. Noel Bairey Merz, Janet Wei, Michel T. Corban, Odayme Quesada, Sandy Joung, Christine L. Kotynski, Jian Wang, Michelle Lewis, Ann M. Schumacher, Ronnda L. Bartel, Hiroshi Takagi, Vishal Shah, Anna Lee, William K. Sietsema, Douglas W. Losordo, Amir Lerman

Summary: This study evaluated the safety and efficacy of intracoronary CD34+ cell therapy in patients with coronary microvascular dysfunction. The results showed that patients receiving CD34+ cell therapy had improved coronary flow reserve, reduced angina symptoms, and improved quality of life after 6 months of treatment. This study supports the potential therapeutic role of CD34+ cells in patients with microvascular angina.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2022)

Article Cardiac & Cardiovascular Systems

Sex-Specific Temporal Trends in Hypertensive Crisis Hospitalizations in the United States

Joseph E. Ebinger, Yunxian Liu, Matthew Driver, Hongwei Ji, C. Noel Bairey Merz, Florian Rader, Christine M. Albert, Susan Cheng

Summary: Despite improvements in overall hypertension control, hospitalization rates for hypertensive crises, especially among men, have steadily increased, along with an increase in the burden of cardiovascular conditions.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Letter Cardiac & Cardiovascular Systems

Detection of subclinical atherosclerosis from PET-CT in patients with breast cancer

Adele Pope, Louise Thomson, Stephanie Cantu, Gayatri Setia, Nare Torosyan, Noel Bairey Merz, Katelyn Atk Ins, Eric M. Anderson, Susan Cheng, Balaji Tamar Appoo

JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY (2022)

Letter Cardiac & Cardiovascular Systems

Mortality Risk in Takotsubo Syndrome Versus Myocarditis

Alan C. Kwan, Jesse Navarrette, Patrick Botting, Melanie T. Chen, Janet Wei, C. Noel Bairey Merz, Joseph E. Ebinger, Susan Cheng

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Editorial Material Cardiac & Cardiovascular Systems

Editorial INOCA and MINOCA: Are Women's Heart Centres the Answer to Understanding and Management of These Increasing Populations of Women (and Men)?

Christine Pacheco, Judy Luu, Puja K. Mehta, Janet Wei, Martha Gulati, C. Noel Bairey Merz

CANADIAN JOURNAL OF CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers

Susan L. Ivey, Hattie Rees Hanley, Catrina Taylor, Eveline Stock, Nirali Vora, Jenny Woo, Sara Johnson, C. Noel Bairey Merz

Summary: Cardiovascular diseases are the leading causes of death among women of all ages. Efforts to reduce CVD in women have stagnated over the past decade, with an increase observed among younger women and women of color. Policy levers are recommended to address CVD in women, including promoting screening for risk factors, enhancing education, and providing support resources.

CLINICAL CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Clinical Practice Variations in the Management of Ischemia With No Obstructive Coronary Artery Disease

Judy M. Luu, Janet Wei, Chrisandra L. Shufelt, Anum Asif, Benita Tjoe, Paul Theriot, C. Noel Bairey Merz

Summary: This survey reveals heterogeneity in the management of ischemia with no obstructive coronary artery disease among US cardiologists, supporting the need for guideline development and highlighting knowledge gaps in therapeutic management and research education for this condition.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Editorial Material Cardiac & Cardiovascular Systems

Heart and brain interactions: is small vessel disease a link?

Carl J. Pepine, C. Noel Bairey Merz

EUROPEAN HEART JOURNAL (2023)

Editorial Material Cardiac & Cardiovascular Systems

ROMA:Women: Innovative Approaches for the First Cardiac Surgery Trial in Women

Mario Gaudino, Stephen E. Fremes, Roxana Mehran, C. Noel Bairey Merz

CIRCULATION (2023)

Review Peripheral Vascular Disease

Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know

Paul Marano, Janet Wei, C. Noel Bairey Merz

Summary: This article reviews recent research progress related to coronary microvascular dysfunction (CMD) and its association with multiple cardiovascular disease processes. CMD is prevalent in patients with signs and symptoms of ischemia and no obstructive epicardial coronary artery disease (INOCA), particularly in women. CMD is associated with adverse outcomes, including the development of heart failure with preserved ejection fraction, in various patient populations. Stratified medical therapy based on invasive coronary function testing can improve symptoms in patients with INOCA.

CURRENT ATHEROSCLEROSIS REPORTS (2023)

Article Cardiac & Cardiovascular Systems

Body Mass Index, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk

Sadiya S. Khan, Lucia C. Petito, Xiaoning Huang, Katharine Harrington, Rebecca B. McNeil, Natalie A. Bello, C. Noel Bairey Merz, Eliza C. Miller, Rupa Ravi, Christina Scifres, Janet M. Catov, Victoria L. Pemberton, Jasmina Varagic, Phyllis C. Zee, Lynn M. Yee, Mitali Ray, Jin Kyung Kim, Abbi D. Lane-Cordova, Jennifer Lewey, Lauren H. Theilen, George R. Saade, Philip Greenland, William A. Grobman

Summary: This study found a significant association between early pregnancy obesity and postpartum hypertension, hyperlipidemia, and diabetes risk. Adverse pregnancy outcomes were related to increased incidence of postpartum hypertension and hyperlipidemia. However, these adverse pregnancy outcomes only partially mediated the association between early pregnancy obesity and postpartum hypertension.

CIRCULATION RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Internal medicine resident education improves cardiac rehabilitation knowledge, attitudes, and referral rates: A pilot study

Maggie Wang, Nare Torosyan, C. Noel Bairey-Merz, Janet Wei, Chrisandra L. Shufelt

Summary: Resident education on cardiac rehabilitation (CR) significantly improved internal medicine residents' knowledge and attitudes towards CR, which also led to a modest increase in referral rates.

AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

No Data Available